180 related articles for article (PubMed ID: 30787081)
1. Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study.
Tsao NW; Lynd LD; Sayre EC; Sadatsafavi M; Hanley G; De Vera MA
BMJ Open; 2019 Feb; 9(2):e023714. PubMed ID: 30787081
[TBL] [Abstract][Full Text] [Related]
2. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.
Tsao NW; Sayre EC; Hanley G; Sadatsafavi M; Lynd LD; Marra CA; De Vera MA
Ann Rheum Dis; 2018 Jun; 77(6):869-874. PubMed ID: 29496718
[TBL] [Abstract][Full Text] [Related]
3. Risk of congenital anomalies in infants born to women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.
Tsao NW; Hanley GE; Lynd LD; Amiri N; De Vera MA
Clin Exp Rheumatol; 2019; 37(6):976-982. PubMed ID: 30943142
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Biologics Utilization and Discontinuation Before and During Pregnancy in Women With Autoimmune Diseases: A Population-Based Cohort Study.
Tsao NW; Lynd LD; Sadatsafavi M; Hanley G; De Vera MA
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):979-986. PubMed ID: 28973840
[TBL] [Abstract][Full Text] [Related]
5. Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis.
Gubatan J; Nielsen OH; Levitte S; Juhl CB; Maxwell C; Streett SE; Habtezion A
Am J Gastroenterol; 2021 Feb; 116(2):243-253. PubMed ID: 33110017
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.
Mahadevan U; Long MD; Kane SV; Roy A; Dubinsky MC; Sands BE; Cohen RD; Chambers CD; Sandborn WJ;
Gastroenterology; 2021 Mar; 160(4):1131-1139. PubMed ID: 33227283
[TBL] [Abstract][Full Text] [Related]
7. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION).
Luu M; Benzenine E; Doret M; Michiels C; Barkun A; Degand T; Quantin C; Bardou M
Am J Gastroenterol; 2018 Nov; 113(11):1669-1677. PubMed ID: 29961771
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use.
Carman WJ; Accortt NA; Anthony MS; Iles J; Enger C
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1109-1118. PubMed ID: 28758274
[TBL] [Abstract][Full Text] [Related]
9. From mother to baby: antenatal exposure to monoclonal antibody biologics.
Pham-Huy A; Sadarangani M; Huang V; Ostensen M; Castillo E; Troster SM; Vaudry W; Nguyen GC; Top KA
Expert Rev Clin Immunol; 2019 Mar; 15(3):221-229. PubMed ID: 30570400
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Zhang S; Martlow TK; Aghajafari F; Asztalos EV; Brocklehurst P; Dutta S; Garite TJ; Guinn DA; Hallman M; Hardy P; Lee MJ; Maurel K; Mazumder P; McEvoy C; Murphy KE; Peltoniemi OM; Thom EA; Wapner RJ; Doyle LW;
PLoS Med; 2019 Apr; 16(4):e1002771. PubMed ID: 30978205
[TBL] [Abstract][Full Text] [Related]
11. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.
Desai RJ; Bateman BT; Huybrechts KF; Patorno E; Hernandez-Diaz S; Park Y; Dejene SZ; Cohen J; Mogun H; Kim SC
BMJ; 2017 Mar; 356():j895. PubMed ID: 28264814
[No Abstract] [Full Text] [Related]
12. Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study.
Vinet É; De Moura C; Pineau CA; Abrahamowicz M; Curtis JR; Bernatsky S
Arthritis Rheumatol; 2018 Oct; 70(10):1565-1571. PubMed ID: 29771477
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
[TBL] [Abstract][Full Text] [Related]
14. Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
Duricova D; Dvorakova E; Hradsky O; Mitrova K; Durilova M; Kozeluhova J; Kohout P; Zarubova K; Bronsky J; Hradska N; Bronska E; Adamcova M; Machkova N; Hruba V; Bortlik M; Lukas M; Malickova K; Lukas M
Inflamm Bowel Dis; 2019 Mar; 25(4):789-796. PubMed ID: 30239799
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
Chaparro M; Verreth A; Lobaton T; Gravito-Soares E; Julsgaard M; Savarino E; Magro F; Biron AI; Lopez-Serrano P; Casanova MJ; Gompertz M; Vitor S; Arroyo M; Pugliese D; Zabana Y; Vicente R; Aguas M; Shitrit BA; Gutierrez A; Doherty GA; Fernandez-Salazar L; Cadilla MJ; Huguet JM; OʼToole A; Stasi E; Marcos MN; Villoria A; Karmiris K; Rahier JF; Rodriguez C; Palomares DM; Fiorino G; Benitez JM; Principi M; Naftali T; Taxonera C; Mantzaris G; Sebkova L; Iade B; Lissner D; Bradley FI; Roman LA; Marin-Jimenez I; Merino O; Sierra M; Van Domselaar M; Caprioli F; Guerra I; Peixe P; Piqueras M; Rodriguez-Lago I; Ber Y; van Hoeve K; Torres P; Gravito-Soares M; Rudbeck-Resdal D; Bartolo O; Peixoto A; Martin G; Armuzzi A; Garre A; Donday MG; de Carpi MFJ; Gisbert JP
Am J Gastroenterol; 2018 Mar; 113(3):396-403. PubMed ID: 29460920
[TBL] [Abstract][Full Text] [Related]
16. Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease.
Long MD; Siegel CA; Abraham BP; Chiorean M; Mahadevan U
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):706-708.e1. PubMed ID: 33549864
[TBL] [Abstract][Full Text] [Related]
17. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
[No Abstract] [Full Text] [Related]
18. In Utero Exposure to Antibiotics and Risk of Serious Infections in the First Year of Life.
Tisseyre M; Collier M; Beeker N; Kaguelidou F; Treluyer JM; Chouchana L
Drug Saf; 2024 May; 47(5):453-464. PubMed ID: 38409516
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
[TBL] [Abstract][Full Text] [Related]
20. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.
Bloland PB; Wirima JJ; Steketee RW; Chilima B; Hightower A; Breman JG
AIDS; 1995 Jul; 9(7):721-6. PubMed ID: 7546417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
